Faqs.org homepage
::
Abstracts index
Abstracts: Big biz relies on PR for 'clicks & mortar' push. GE to defend its 'ecomagination'. Political consumers punish/support brands
Abstracts: Big Blue shifts to pink: Pan-European campaign touts service. Coordinating big blue: IBM's automated sales system improves communication
Abstracts: Big brother on the game. Working relationship. Taylored to fit
Abstracts: Big business is high on the Honolulu method. A freeze-dryer and a fertile imagination. GlaxoSmithKline presents a biotech facade
Abstracts: Big business: rising obesity rates add up to a growing industry in plus-size design. Technology: Shape up and ship out
Abstracts: Big chance, little effort, lots of benefits. Financial instruments: an international issue. In anticipation of a maiden standard
Abstracts: Big changes afoot in a tough market: mounting commercial pressure in the global custody arena has forced players to look long and hard at their positions and long-term prospects. Some have decided to call it a day
Abstracts: Big chill puts building revival under threat. The game's up, regulator tells gas investors. Gas shake-up turns spotlight on brown
Abstracts: Big cross-border mergers may remain rare occurrences in Europe's financial sector. Mergers & acquisitions
Abstracts: Big crowds, big technology herald return to Las Vegas for Annual Convention. Digital cameras going mainstream
Abstracts: Big DOD audit push starts with $90 million Contract Purse. Northrop Grumman nets $25.7 million air node deal. Pentagon needs better contract oversight: Thinktanker
Abstracts: Big doesn't have to be beautiful. Speculators circle round healthcare trust. Vulture funds don't worry us, say trust managers
Abstracts: Big food companies face anti-biotech PR assault. Reality TV spurs'in-your-face' pitches. Price, not bird flu, tops list of food worries
Abstracts: Big Four defend non-audit earnings. Gold rush: Accountants are suddenly in demand but in short supply. Ambition
Abstracts: Big Four hit by 14% fall in FTSE 100 audit client fees. Big Four suffer 16% fall in FTSE 100 fees. Does practice make perfect?
Abstracts: Big four jockey for position in industrial gases market. The big squeeze. Sterling fall cheers engineers
Abstracts: Bigger fish to fry. It doesn't add up: Increasingly, companies are recruiting CFO's without formal accountancy qualifications
Abstracts: Bigger slice for pizza as burgers recover UK: IMAGINATIVE MARKETING SAVES BEEF. Dairy Council shrugs off consumer threat
Abstracts: Bigger spending on store credit cards UK: JBB BRANDS IN TV CAMPAIGN. Kleenex adds a touch of Velvet
Abstracts: Biggest North Korean threat is nukes sale to terrorists: Author. North Korean nukes? 'Don't know' means 'likely' - Senator
Abstracts: Big growth potential cited for diversified Dynalectron. Heavy insider buys underline Rouse's cash flow growth
Abstracts: Big growth potential cited for diversified Dynalectron. Price lull induced big buys by Thousand Trails insiders
Abstracts: Big ideas from the midsize: treasury & risk management's first annual middle-market survey polled 226 finance executives from companies with less than $1 billion in revenues
Abstracts: Big is beautiful. The selling of a scandal. Driving force at the helm
Abstracts: Big Labor rips Nike at Big PR's annual outing. Ethical reasoning lacking in adland. Philip/Morris regrets death study
Abstracts: Big pharma wants you. The rise of venture capital and biotechnology in the US and Europe. Term sheet trends in the venture capital market
Abstracts: Big players go for growth. Brighter view for Birchin. Facilities management: companies tune in to FM
Abstracts: Big players scrambling for distribution channels. Marketing assists product design; HP tries to anticipate customers' demands
Abstracts: Big PRSA chapters ousted APRs. PRSA assembly rejects 'democracy'. APRs win at PRSA; may move
Abstracts: Big regional differences as economy slows. Service sector hit by changed recession cycle. The UK economy: miracle or mirage?
Abstracts: Big spirits push is up to us, says UDV More Czech beers head for UK UK: DOUWE EGBERTS TESTS NEW DISPLAY SCHEME
Abstracts: Big things for Wiggins. Getting the House in order. Debenhams
Abstracts: Bijan Wicked For Men By Bijan Eau De Toilette Spray. Bijan Wicked For Women By Bijan Body Lotion. Bijan Wicked For Men By Bijan Hair & Body Shampoo
Abstracts: Bijan Wicked For Women By Bijan Fragrance Spray. Bijan Wicked For Women By Bijan Shower Gel. Bijan Wicked For Men By Bijan After Shave Balm
Abstracts: BILLBOARDS FLY BY ON BROADBAND HIGHWAY. COMMUNITY FOCUS: TRADITIONAL INDUSTRY COMMUNITY SITES LOOK TO E- COMMERCE TO ENHANCE THEIR CONTENT FOCUS
Abstracts: Billion dollar babies-biotech drugs as blockbusters. Getting dumped. Crystal gazing: Biotech's financial outlook
Abstracts: Billion-dollar market blossoms as botanicals take root. Implementing biofuels on a global scale. Can biofuels finally take center stage?
Abstracts: Billion pound boost for Top 60 firms. The year of uncertainty. Listen to investors for a thriving audit market
Abstracts: Billiton
Abstracts: Billiton. Decimation of an industry. Pechiney
Abstracts: Bill provides DD(X) rescue: Raptor, JSF, FCS fare well. Leaders of contractors may be liable to global court charges
Abstracts: Bills to protect women seeking business loans could bury corporations. Centralization, written reports key management of foreign exchange risk
Abstracts: Bin your brochures. Theirs and ours. Time is of the essence
Abstracts: Bioanalytical Systems, Inc. (BASI). Rheometric Scientific, Inc. (RHM)
Abstracts: Biocompatibles International. Biocompatibles heads for the heart
Abstracts: Biocontrol genome deciphered. Energy well spent on a prokaryotic genome. A window on the dynamics of biological switches
Abstracts: Biodefense hampered by government-industry conflict. Biodefense: birth of an industry. 'Smart dust' sensor networks could transform battlefields: Expert
Abstracts: Biofilms strike back. Green light for mosquito control. A reverse genetic, nontransgenic approach to wheat crop improvement by TILLING
Abstracts: Bioglan Pharma. Fulcrum Pharma. SR Pharma
Abstracts: Bioglan Pharma. Oxford Molecular. Phytopharm
Abstracts: Bioinformatics attracts big guns. Cash-strapped biotechs find financing alternative. Erbitux diagnostic latest adjunct to cancer therapy
Abstracts: Bio-key International (SACM). Internet Pictures Corp. (IPIX). E.mergent, Inc
Abstracts: Biomaterials science and high-throughput screening. Next-generation protein drugs. Preservation of mammalian cells-learning nature's tricks
Abstracts: Biomechanical analysis of materials handling manipulators in short distance transfers of moderate mass objects: Joint strength, spine forces and muscular antagonism
Abstracts: Biomechanical exploration on dynamic modes of lifting. Determination of the effect of lift characteristics on dynamic performance profiles during manual materials handling tasks
Abstracts: Biomechanically and electromyographically assessed load on the spine in self-paced and force-paced lifting work
Abstracts: Biomechanical measures. Simultaneous measurements of posture and movements of head and trunk by continuous three-dimensional registration
Abstracts: Biomechanical risk factors for occupationally related low back disorders. The influence of lift frequency, lift duration and work experience on discomfort reporting
Abstracts: Biomet Inc. Calgene Inc. Amgen Inc
Abstracts: Biometrics and its benefits. Rising stars: high-tech high-flyers can bring significant returns for the shrewd investor
Abstracts: Bionic marketing: Can you sell hearts the same way you sell hamburgers? How Do You Sell Computer Programs?
Abstracts: Bio-ontologies -- fast and furious. Overhauling the PDB. Are the current ontologies in biology good ontologies?
Abstracts: Bio Plus+ Supplement Chewable Tablets; Capsules. Aircare Dietary Supplement Tablets. Healthaid Dietary Supplement Tablets
Abstracts: BioPulse faces US and Mexican malpractice probes. Analysts: Isis-Lilly deal validates antisense. Company, academics argue over data
Abstracts: BIO reaches adolescence. Pessimistic response to FDA leadership change. Agbiotech firms realign product focus
Abstracts: Biore Shine Control Moisturizer; Clay Mask; Blotting Sheets. Australian Gold Body Kisses Daily Moisturizer
Abstracts: BioSpecifics Technologies Corp. (BSTC). Ostex International, Inc. (OSTX). Nymox Pharmaceutical Corp. (NYMX)
Abstracts: Biotech bloodshed. Rhein Biotech. GeneMedix plans generic biotech
Abstracts: Biotech buybacks: good or bad? Beware the biotech barker. Biotech IPOs-flop or pop?
Abstracts: Biotech companies adapt to big pharma mergers. Genzyme acquires Cell Genesys. Demise of the life science company begins
Abstracts: Biotech consulting, investing by NIH scientists curbed. The business of developing antibacterials. Lester Crawford
Abstracts: Biotech - Europe Tries to Close the Barn Door on Mad Cows. Energy trading. Wi-Fi revolution
Abstracts: Biotech - Europe Tries to Close the Barn Door on Mad Cows. Fixed Income - The Junk Bond Market Smells Like a Rose
Abstracts: Biotech holds steady in Q4. Any diamonds in the diagnostic coal? Celltech acquisition sends mixed messages
Abstracts: Biotechnology and the European public. GMO roundup. New Zealand's comprimise calms GMO lobby
Abstracts: Biotechnology financing dilemmas and the role of special purpose entities. Keeping it real with investors
Abstracts: Biotechnology: keep an eye on new faces. Biotechnology companies: out of fashion. Biotechnology: bouncing babies
Abstracts: Biotechnology venture capital booms in Japan. Drug bill cuts force firms overseas. GM food regulatory terms debated
Abstracts: Biotech patents: Looking backward while moving forward. Changing patent strategies: what will they mean for the industry?
Abstracts: Biotech's knowledge trust. Probity gone nuts. Rogan steps down as USPTO director
Abstracts: Biotech takes aim at large anti-estrogen markets. Stem cell therapy or snake oil? Poorer nations turn to publicly developed GM crops
Abstracts: BioTransplant Incorporated (BTRN). NewBiotics Inc. CuraGen Corporation (CRGN)
Abstracts: Biotrin assay to monitor cervical cancer exposure rates. Production technologies change flu vaccine landscape
Abstracts: Bipartisan analysts ask Hill to add troops. Analyst calls weapons buys 'amazing' given Pentagon mismanagement
Abstracts: Bird's eye view. The innovator. Room service
Abstracts: Birmingham Capital Management Company. Roulston & Company, Inc. Security Management Company
Abstracts: Birmingham's driving ambitions. The beauty of a broader base. In the big league
Abstracts: Birmingham starts to build its council tax system. All of the problems but none of the cash: Radnorshire sets off on the council tax path
Abstracts: Birthday bashes make old news good news. Honda added products every month. Prepaid gas card fuels Harley-Davidson anniversary promotion
Abstracts: Bitten by the corporate governance bug. Integrating global treasury management. Getting a clear view
Abstracts: Bitter battles in the beer business. Pleasure domes in the bunker. Outsiders on the inside
Abstracts: Biz books step up ad battle with trade mags. Communicating the whole story. Fine tuning lead management
Abstracts: Black Country in ebullient mood. Stockbrokers reel from musical chairs. Economic uncertainty prevails
Abstracts: Black gold out of the cold. Bar wars. Promise me the moon
Abstracts: Black Hills Corporation (BKH). Emera Incorporated (EMA: TSE). Electrizitats-Gesellschaft Laufenburg AG
Abstracts: Black hole or new galaxy? Indonesian boost. Raytheon B
Abstracts: Blackpool pleased with study on casino feasibility. Atronic pioneers Danish project. Grosvenor Casino pays out record half million jackpot
Abstracts: Black Radiance Precious Lips Compact. Black Radiance Exotic Eye Compact. Black Radiance Indelibly Radiant Lipstick
Abstracts: Black's expands into superstores. Throop Photo Supply. Ginn Photographic
Abstracts: Blame game. Irreverent thought. What's wrong with conjoint analysis?
«
previous page
next page
»
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.